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Abstract
The nascent polypeptide-associated complex (NAC) is a highly conserved
heterodimer known to play an important role in protein folding and localization during
metazoan development. Evidence in different model systems indicates that removal of
either subunit of the NAC, i.e. α- or β-NAC, is sufficient to generate misfolded protein
stress in the endoplasmic reticulum (ER), resulting in the activation of the ER-specific
unfolded protein response (UPR). What is not yet understood is the nature of the UPR
depending on which subunit of the NAC is depleted. My research is focused on
characterizing the specific UPR outcomes induced upon depletion of either α- or β-NAC
during misfolded protein stress in the ER. Assessment of UPR outcomes revealed that
depletion of the C. elegans NAC homologues icd-1/NAC and icd-2/NAC shared
unique responses relative to the subunit depleted. Specifically, depletion of ICD-1 led to
increased ER specific chaperone expression and robust attenuation of protein synthesis
when compared to depletion of ICD-2. Along with managing protein homeostasis during
ER stress, I also found that specific components of the NAC and UPR actively contribute
to cell differentiation programs, e.g. embryos depleted of ICD-1 displayed altered
neuronal marker expression during ER stress, while other cell-type specific markers
remained unchanged. These results suggest the individual subunits of the C. elegans
NAC are functional when unbound and contribute differentially to the activation of the
UPR when one subunit is in excess relative to the other. Such findings may provide
insights into the pathology of diseases such as Alzheimer’s, in which the 1:1
stoichiometry of the NAC subunits is disrupted.
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1 Introduction
1.1 Protein folding
Cells require functional proteins to survive and reproduce. To achieve a
functional native state, proteins must first properly fold. Prior to attaining a terminally
functional conformation, nascent polypeptides traverse various unfavorable
conformations that, if retained, would result in misfolded non-functional proteins or
misfolded proteins possessing altered functionality1, 2. Given the importance of achieving
accurately folded proteins for cell viability, how do cells respond in the presence of
increased levels of misfolded proteins? One coping mechanism is induction of protein
degradation processes such as the ubiquitin proteasome system, which degrades
misfolded proteins tagged with multiple ubiquitins. However, because protein synthesis
is energetically costly, engaging protein degradation mechanisms may be a wasteful
expenditure of energy if not necessary. On the other hand, failure to remove misfolded
proteins may have detrimental effects on cellular function. Therefore in an attempt to
avoid the degradation of energetically costly proteins without compromising cellular
integrity, cells employ various quality-control mechanisms to ensure accurately folded
mature polypeptides3, 4.
A critical mechanism employed for proper protein folding is the induction of
chaperones. This system assists protein folding by preventing incompletely folded
polypeptide chains from forming unfavorable interactions while also lowering the
activation energy of energetically unfavorable folding steps that polypeptide chains often
have to traverse to achieve their final structure5. Due to the complex and highly
congested environment in which proteins must reach their native state, proper folding
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often requires auxiliary folding mechanisms (e.g. chaperones)6, 7. However, under
appropriate in vitro conditions proteins are able to reach a native functional conformation
in the absence of chaperones8. This evidence suggests polypeptide chains hold sufficient
instructions to direct their own folding, but additional support systems are required due to
the complex cellular environment in which the protein is folding. To fully understand the
process of protein folding, one needs to understand the numerous elements integral to this
process, how they function to drive proper folding and how the cell responds when these
systems falter.
Protein folding is an extensively regulated process essential for cellular function
and viability. Alterations to this process often have adverse effects. Under
circumstances typically involving exogenous stressors, proteins may fail to fold properly
during translation or, once folded, retain their native state. This failure is often sufficient
to trigger stress-response mechanisms that can initiate the death of the cell via apoptosis9.
Apoptosis is a genetically well-defined mechanism that triggers the activation of caspases
and proteases that cleave specific cellular targets to result in the death of the cell.
Apoptosis removes damaged cells that could otherwise be dangerous to the organism
such as cells containing a large number of misfolded proteins10. As such, diseases that
generate misfolded protein stress affect the initiation of apoptosis; most
neurodegenerative disorders generate large numbers of misfolded proteins that result in
neuronal apoptosis, while a vast majority of cancers up-regulate protein-folding
mechanisms during rapid cell division to avoid misfolded protein stress and the initiation
of apoptosis11, 12. The direct link between misfolded protein stress and disease
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necessitates a clear understanding of protein folding mechanisms, how they function in
healthy cells, and how they malfunction during disease pathology.
Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s
disease (PD), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS) and prion
diseases share a common pathogenic mechanism while possessing diverse genetic
predispositions. A reoccurring theme in neurodegenerative diseases is the formation of
insoluble fibrils resulting from misfolded protein aggregates11. Alterations in protein
homeostasis, sequentially leading to misfolded proteins, produce these aggregates which
mainly consist of repeating fibers composed of misfolded proteins in a β-sheet
conformation11, 13. These insoluble fibrils are responsible for the neuronal apoptosis that
produces the phenotypes commonly observed in neurodegenerative diseases, e.g. loss of
motor control and decreased cognitive function17. It is therefore evident that apoptosis,
triggered by the presence of intractable misfolded proteins, is a fundamental process of
disease onset and progression14.
In healthy cells, mechanisms that control the quality of protein folding bind
nascent polypeptide chains during translation and prevent the formation of inappropriate
tertiary structures to yield a mature functional protein15, 16. However, quality control
mechanisms appear to malfunction during neurodegeneration, that is, proteins in neurons
fail to reach a native conformation, resulting in pre-mature apoptosis in these cells17.
This outcome is likely due to a decreased or desensitized ability to cope with increased
misfolded proteins, a theory supported by the decreased chaperone activity commonly
observed in neurodegenerative disease18. Cells undergoing stress must critically engage
folding mechanisms to adapt and prevent lethal levels of proteotoxicity19. That cells are
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able to withstand certain levels of misfolded protein stress and remain viable reveals the
existence of a response that mitigates this stress and triggers apoptosis only when a
threshold is exceeded. As such, one plausible contribution to neurodegeneration is when
upstream regulatory factors fail to properly activate compensatory folding mechanisms,
triggering cell death well below levels that would normally trigger cell death.
As with neurodegeneration, cancer is another class of disease intimately
associated with protein folding and apoptosis, but in a much different way. Precancerous as well as cancerous cells often proliferate at an above average rate, requiring
the accelerated expression of certain proteins that are often unable to fold properly and
are, therefore, abnormal in function20. Normally, this scenario would lead to the rapid
accumulation of misfolded protein and eventually apoptosis; such a response by stress
response mechanisms that initiate apoptosis protects the organism. How do successful
cancerous cells mitigate, or even prevent, the increased misfolded protein stress that can
lead to apoptosis? The “micro-evolution” of a cancer cell provides an answer 21. Precancerous cells unable to withstand the pressure of sustained levels of misfolded proteins
stress will eventually undergo apoptosis and die12. Successful cancer cells survive this
pressure and evade apoptosis due to the acquisition of mutations that allow the cell to
manage the dramatically increased rates of protein synthesis, both functional and
misfolded, during rapid cell divisions. Due to the increased proliferation of most tumor
cells, in combination with mutations that often affect protein structure, proteins in these
cells, on average, possess less than one quarter the half-life when compared to proteins in
healthy cells22. This increase in protein turnover is accompanied by increased translation
and protein-folding capacity in the form of elevated chaperone expression. As proteins of
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the highly mutable cancerous cells become unstable, chaperone activity increases23.
Consistently, the vast majority of tumors, regardless of type, overexpress heat shock
proteins, including of those in the HSP90 and -70 families12. In addition, successful
cancerous cells are thought to contain other mechanisms for coping with increased
misfolded protein stress, including those that regulate chaperone activity. As with
neurodegeneration, understanding the role of protein folding and misfolded protein
stress-response in cancer development will likely provide insights into disease pathology
and treatment.
1.2 The Unfolded Protein Response (UPR) and its role in misfolded protein stress
The establishment and maintenance of proper protein folding and turnover,
otherwise known as protein homeostasis, is essential for maintaining cellular integrity,
and cells possess robust and redundant systems dedicated to this process. In eukaryotes,
the endoplasmic reticulum (ER) is essential for the folding and modification of both
secreted and transmembrane proteins. The protein folding process in the ER involves
several steps, increasing the possibility that any individual step may generate a misfolded
protein. As a buffer against the accumulation of misfolded protein, the ER contains a
network of mechanisms that can mitigate potential proteotoxic levels of misfolded
proteins within the organelle 24, 25, 26. This network of stress responses is collectively
known as the unfolded protein response, or UPR.
The UPR is an ER-specific misfolded protein sensor that determines the fate of a
cell under misfolded protein stress. Highly conserved amongst eukaryotic organisms, the
UPR is activated in response to misfolded protein accumulation in the ER and maintains
homeostasis through several mechanisms that mitigate the accumulation of misfolded
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protein, including: 1) increased expression of ER-specific chaperones; 2) attenuation of
protein synthesis, and; 3) translocation of terminally misfolded proteins from the ER to
the cytosol for proteosomal degradation27. These interventions can rescue cells
undergoing low levels of misfolded protein stress for relatively short periods of time.
However, under acute and/or sustained levels of misfolded protein stress, the UPR is
often unable to adequately suppress the accumulation of misfolded protein, and a
proteotoxic environment ensues. In these cases the UPR typically triggers cell death,
primarily via apoptosis27. As such, the components of the UPR cooperate to control the
balance between cell survival and cell death in the face of misfolded protein stress, a
balance determined by the length and intensity of the stress.
The UPR consists of three ER transmembrane proteins that work in parallel to
engage various signal transduction pathways. Inositol-requiring enzyme-1 (IRE1),
protein kinase RNA-like endoplasmic reticulum kinase (PERK) and activating
transcription factor-6 (ATF6) each have the ability to sense misfolded protein stress in
the ER and initiate responses to manage the resulting stress27. While a number of
responses are generated by the UPR, three specific outcomes appear to be essential to
save the cell: attenuation of translation, up-regulation of chaperone expression and
degradation of misfolded protein. Each outcome results directly from UPR activity, and
in some cases these signaling pathways behave redundantly27.
The three arms of the UPR are maintained in an inactive state in the absence of
misfolded protein stress in the ER, primarily through an interaction with glucoseregulated protein-78 (GRP78)/BiP, a highly conserved ER-specific chaperone that
controls the activation of UPR signaling28. GRP78/BiP binds to the lumenal moiety of

7
each component, preventing activation; this chaperone possesses a higher affinity,
though, for misfolded proteins. Increases in levels of misfolded proteins titrate
GRP78/BiP away from IRE1, PERK and ATF6, allowing for their activation29. As such,
GRP78/BiP behaves as a sensor of misfolded protein stress in the ER that modulates
response; as more misfolded protein accumulates, more GRP78/BiP dissociates from
UPR components, strengthening the stress response in parallel with the accumulation of
misfolded protein.
One can understand the complete contribution of the UPR to management of
misfolded protein stress by analyzing the individual contributions made during this
response, including the attenuation of translation. Provided with the appropriate stimuli,
PERK dissociates from GRP78/BiP and homodimerizes to promote its auto
phosphorylation and activation. PERK subsequently phosphorylates the α-subunit of
eukaryotic initiation factor-2 (eIF2α), preventing the formation of the eIF2α-tRNAmet40S translation initiation complex30, 31. Phosphorylation of eIF2α represses general
translation, but paradoxically promotes the translation of the pro-survival activating
transcription factor-4 (ATF4) and the pro-apoptotic factor C/EBP homologous protein
(CHOP) 32. In this way, PERK activation and the resulting attenuation of translation
ultimately leads to the generation of both pro-survival and pro-apoptotic signals. An
additional outcome of Phosphorylated eIF2α is ATF4 dependent expression of ER stress
response element (ERSE) target genes33. The ERSE promoter domain targets the
expression of specific genes containing this conserved motif, such as ER specific
chaperones GRP78/BiP and GRP94, in the presence of ER stress34. ATF6 and IRE1
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contribute to transcriptional up-regulation of ER-specific chaperones thus activation of
ERSE target genes reflects the overlap amongst components of the UPR35, 36, 37.
The increased expression of ATF4 leads to the up regulation of chaperone
production via the transcription factor’s ability to bind to the ER stress response element
(ERSE). In fact, all three arms of the UPR are able to increase chaperone expression via
the ERSE. During the UPR, activated ATF6 migrates from the ER to the Golgi apparatus
where the protein is cleaved to reveal its nuclear localization domain and subsequently
acts as a transcription factor to directly up regulate the expression of ER specific
chaperones responsible for augmenting ER folding capacity35, 36. In addition, IRE1
indirectly induces the transcription of ERSE target genes using intrinsic endoribonuclease
activity to splice a 26 base intron from the mRNA of the X-box binding protein-1 (XBP1)
transcription factor. The subsequent translation of this mRNA generates a potent
transcription factor that induces ER specific chaperone expression via ERSE. Depending
on the source and strength of the misfolded protein stress in the ER, one or more of these
arms of the UPR can lead to a dramatic increase in chaperone expression, contributing to
the mitigation of the stress and the rescue of the cell37.
In addition to the attenuation of translation and increase in expression of
chaperones, successful rescue of stressed cells requires the degradation of proteins
misfolded beyond repair. To prevent accumulation of these proteins in the ER, the UPR
induces their retro-translocation to the cytosol for degradation primarily via the ubiquitin
proteasome system in a process termed ER-associated degradation (ERAD). During this
process, E1, E2 and E3 ubiquitin ligases covalently link ubiquitin to misfolded proteins.
Carrier proteins containing an Ubl or Uba structural domains bring tagged proteins to the
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proteosome for enzymatic degradation and recycling of the resulting amino acids38.
Autophagy-mediated ERAD involves the formation of small double membrane structures
termed autophagosomes. Autophagsomes collect dysfunctional organelles as well as
misfolded proteins and fuse with lysosomes, leading to the breakdown of materials within
these structures primarily by proteases39. The UPR triggers the initiation of ERAD by
facilitating the conversion of LC3, a pro-autophagic regulator essential for the formation
of autophagosomes. LC3 conversion requires pro-LC3 cleavage to yield LC3-I in the
cytosol. Cleaved LC3-I is further modified with the addition of phospholipids to LC3-II,
which forms the membrane structure of autophagosomes40. PERK activity, leading to
eIF2α phosphorylation, indirectly contributes to autophagy-mediated ERAD via direct
eIF2α up regulation of LC341.
The intended outcome of the UPR-initiated events detailed above is to “buy” the
cell time to mitigate the level of misfolded protein and survive. If misfolded proteins
continue to accumulate regardless of the cell-saving pathways employed, the UPR has the
ability to initiate apoptosis, thereby eliminating a cell in which the damage is beyond
rescue42. Apoptosis can be initiated via the PERK or IRE1 pathway, but in either case,
the loss of the cell is double-edged sword; elimination of damaged cells can prevent
further damage to healthy cells to help maintain organismal viability, but depending on
the cell type eliminated, this cell death can also leave the organism debilitated, negatively
affecting viability. To understand how misfolded protein stress is well-managed in
healthy cells, and perhaps mismanaged during disease, my research is focused on what
appears to be a central component to this process, a translational chaperone known as the
nascent polypeptide-associated complex, or NAC.
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1.3 The NAC and its contributions to the management of misfolded protein stress
As a translational chaperone responsible for assisting in both protein transport and
folding during translation, the nascent polypeptide associated complex (NAC) is an
integral component of protein homeostasis. The NAC is a heterodimeric complex
composed of a α- and β- subunit bound to the ribosome near the polypeptide exit tunnel.
Like other co-translational chaperones, the NAC is thought to associate with nascent
polypeptide chains exiting the ribosome to ensure proper folding and transport. In
addition, the NAC appears to contribute to stress responses regulated by the UPR43. Due
to the overlapping functions between the NAC and the UPR in regulating protein
homeostasis, the NAC is a suitable candidate for exploring misfolded protein stress
coping mechanisms in relation to the UPR.
For the NAC to engage its function as a ribosomal co-translational chaperone, the
α- and β- subunits must be in a 1:1 stoichiometry44. Although to date the molecular
function of the NAC has not been precisely defined, the heterodimeric complex appears
to have numerous roles and has been implicated as a 1) transcription regulator, 2)
translation regulator, 3) ribosomal chaperone, 4) ER trans-locater, 5) mitochondrial translocater, 6) negative regulator of apoptosis and 7) regulator of autophagy45, 46. Studies
involving the yeast NAC homolog, composed of Edg1 (β- subunit) and Edg2 (αsubunit), suggest that the NAC functional complex is a translational chaperone that
interacts with cytosolic chaperones47, 48, and 49. This is based on evidence showing the Nterminus of Egd1 binds the ribosome close to the amino acid exit tunnel as well as
specifically binding to the ribosomal protein rpl-3150, 51. Pech et al. also showed Edg2
can bind to ribosomal protein rpl-17, a protein neighboring rpl-31. Both rpl-31 and rpl-
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17 are surrounded by rRNA and in close proximity with newly folding peptides as they
exit the ribosome51. The crystal structure of human α-NAC revealed a nucleic-acid
binding region within the α-subunit that possesses a stronger affinity for ssRNA than
DNA, suggesting the NAC may stabilize binding of the ribosomal complex via an
association with rRNA surrounding the amino-acid exit site52, 53. Furthermore, rpl-31 is a
contact point for the co-chaperone ribosome associated complex (RAC) and the ER
translocation signal recognition particle (SRP) protein receptor54, 55. Double deletions of
the RAC chaperone partner stress 70 B (SSB) and the NAC led to synergistic growth
defects and increased sensitivity to translation inhibitors56. In addition, yeast NAC
associates with nearly all nascent peptides on translating ribosomes and modulates SRP
binding to nascent peptides49. In combination, these observations support the hypothesis
that the NAC is a translational chaperone that regulates SRP receptor binding to the
ribosome therein affecting translocation of proteins into the ER.
While the NAC function appears to be essential for proper protein folding and
localization in healthy cells, its individual subunits also appear to contribute protective
functions in cells undergoing misfolded protein stress. During sustained stress, βNAC is
thought to both dissociate from ribosomes and function as a cytosolic chaperone to
prevent protein aggregation. βNAC is able to interact with the major cytosolic chaperone
family members HSP70 and HSP90 while lacking the canonical ATPase domain found in
most chaperones57. Therefore βNAC likely acts as a cytosolic chaperone in a cooperative
manner to maintain proteostasis. In addition to βNAC’s independent function, the αNAC subunit possesses a nucleic acid binding region that is exposed only after
dissociation from βNAC, allowing αNAC to function independently as a transcriptional
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co-activator that may up regulate expression of GRP78/BiP58. With its varied roles as a
complex and as individual subunits, the NAC is uniquely positioned to manage protein
folding in both healthy cells and those undergoing misfolded protein stress57. However,
these collective functions are likely engaged to varying extents based on stress severity as
well as the cellular concentrations of individual NAC subunits.
Deletion of NAC-encoding genes in yeast generates no detectable defects, while
NAC knockout mutations in higher eukaryotes, including fruit flies, worms and mice,
lead to early embryonic arrest59, 60, 61. Therefore the lethal NAC mutant phenotype
reflects the putative necessity of a functional complex and individual subunits for normal
cell function, management of misfolded protein stress and overall viability.
βNAC depletion in Caenorhabditis elegans is sufficient to initiate ER stress and
trigger up-regulation of ER-specific chaperones associated with the UPR62. Similarly,
αNAC ablation by RNA interference in HeLa S3 cells leads to increased expression of
several markers associated with an active UPR63. α- and βNAC have been implicated
independently as negative regulators of the mitochondrial apoptotic pathway; consistent
with the depletion of α or βNAC dramatically increasing apoptosis in cell cultures and C.
elegans during embryogenesis, respectively63, 64, 65. Alternatively, α or βNAC overexpression is sufficient to rescue cells normally targeted to undergo apoptosis64, 63. It is
important to note that in all of these experiments the levels of a single NAC subunit were
altered (either α or βNAC) while the level of the remaining subunit remained unaltered.
Together these results suggest a connection between the NAC, the UPR and the control
of apoptosis during misfolded protein stress. As such, regulating the cellular
concentration of NAC subunits relative to each other may serve as a way to cope with
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misfolded protein stress and determine cell fate. Consistent with this model, NAC levels
are altered in diseases associated with protein folding dynamics: βNAC is downregulated in Alzheimer’s disease, while αNAC is up-regulated in certain types of
cancers66, 67. The potential involvement of NAC function in the pathology of human
diseases emphasizes its importance, our need to understand its function and suggests
independent functions of the individual NAC subunits likely arise upon activation of the
UPR.
1.4 The role of α-NAC and the UPR in cellular differentiation
In addition to assisting cells in maintaining protein homeostasis under stress,
alterations to cellular concentrations of αNAC appears to affect the normal progression of
specific cell types through differentiation. During erythroid cell differentiation, αNAC is
expressed in undifferentiated progenitor cells and is suppressed once progenitor cells
become terminally committed. Ectopic αNAC expression in erythroid progenitor cells in
culture leads to accelerated differentiation, whereas αNAC depletion in these same cells
abolishes hemoglobin production68. In developing CD8+ T cells, αNAC expression is
down regulated as differentiation progresses. Furthermore, αNAC ablation via antisense
technology in human CD8+ T cells leads to increased levels of differentiation and of
activation markers as well as increased cell proliferation69. Interestingly, during normal
bone development osteoblasts express higher levels of αNAC mRNA relative to βNAC70.
Phosphorylation of serine residue 43 translocates αNAC to osteoblast nuclei where it acts
as a developmentally regulated transcriptional co-activator to increase bone matrix
production. Knock-in mutant mice (αNAC-S43A) displayed decreased levels of nuclear
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αNAC, inappropriate bone specific gene expression, decreased levels of immature bone
tissues and increased levels of osteocyte differentiation markers70.
The interaction of αNAC with the UPR is consistent with recent evidence
implicating the UPR in the differentiation of specific cell types. αNAC transcriptional
co-activator activity appears to regulate ATF4 mediated transcription during osteoblast
development71. Similarly, α-NAC activity in erythroid cell differentiation parallels the
strong activation of PERK in immature erythroid progenitor cells; both activities
diminish as cells reach maturity72. In mice, experiments with hematopoietic cells
carrying a fluorescent UPR reporter construct, that indicate IRE1-mediated XBP1
splicing is active during early stages of CD8+ T cell differentiation and undetectable in a
more mature CD8+ T cell population, while IRE1 homozygous mutant mouse embryonic
fibroblasts are defective in osteoblast differentiation73. Furthermore, the promoter region
of the osterix transcription factor, an essential transcription factor for bone development,
possesses two regulatory motifs that are bound by XBP1 during osteoblast
development74. These observations support the notion that along with promoting protein
homeostasis during ER stress, specific components of the NAC and UPR actively
contribute to differentiation.
1.5 Experimental analysis and predictions
Our understanding of the role of the NAC in metazoans comes primarily from
studies of the genetic model organism C. elegans, a ubiquitous nematode that has been
widely used to elucidate the mechanisms of cell stress responses and apoptosis. In this
regard, this organism has highly conserved pathways for both the UPR and apoptosis, and
much of what we know about both processes was originally discerned in this organism.
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C. elegans contains homologs of each of the three ER specific transmembrane proteins
that constitute the UPR, and each pathway has been extensively studied in the context of
knockout mutants64, 75. In addition, C. elegans is very well characterized for apoptosis,
and its core apoptotic proteins are well conserved within a wide spectrum of species. As
such, C. elegans provides the ideal model organism for the study of the NAC in relation
to the UPR and apoptosis, as many of the extant mutants used to characterize the UPR
and apoptosis provide an excellent starting point for elucidating the relationship of UPR
stress response elements and the NAC.
Like its homologs, the C. elegans NAC consists of two subunits: ICD-1/β-NAC
and ICD-2/α-NAC, both of which are required for viability. The nomenclature of these
proteins, inhibitor of cell death (ICD), reflects the initial phenotype associated with the
NAC in C. elegans; depletion of either subunit dramatically increases apoptosis during
embryonic development, while overexpression of β-NAC suppresses apoptosis64. In
subsequent studies, depletion of the NAC was also shown to induce misfolded protein
stress in the ER, resulting in the up-regulation of the UPR62. While these findings have
shed light on the relationship between the NAC, misfolded protein stress and cell death,
many questions remain. Is the apoptosis observed upon depletion of either NAC subunit
the direct result of UPR activity? Does depletion of one subunit of the NAC free the other
subunit to function independently when the UPR is active? If so, do the dynamics
amongst individual subunits of the NAC and the UPR lead to altered differentiation?
Answers to these questions will provide insights into the role of the NAC in protein
homeostasis and control of apoptosis during stress, and clarify how misregulation of the
NAC might contribute to development of disease.
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To test the hypothesis that the individual subunits of the NAC can function
independently when the ER-specific UPR is active in C. elegans, a series of experiments
were designed where icd-1 and icd-2 were removed by RNAi feeding in samples with an
active UPR. RNAi depletion of either icd-1 or icd-2 renders the other subunit in relative
excess. This depletion strategy allowed for assessment of individual subunit activity in
cells with an active UPR. Along with adult viability in these treatments and differences
in differentiation, UPR specific outcomes were assessed: 1) ER specific chaperone
expression and localization 2) changes in presence of lysosomes as a measure of
increased protein degradation and 3) translation attenuation.

2 Methods
2.1 Maintenance of C. elegans stock strains
C. elegans strains were maintained at standard laboratory conditions on Carolina
Nematode Growth Media (NGM) seeded with OP50 feeder bacteria. The OP50 feeder
bacteria were generated from frozen stocks maintained at – 70° C that were shaken
overnight in liquid LB broth at 37° C. Gravid adults were transferred to fresh NGM
plates seeded with OP50 feeder every 3 to 5 days to maintain stock strains.
2.2 Mounting C. elegans embryos for microscope imaging
C. elegans embryos were mounted onto agar pads composed of 0.05 g Bacto agar per mL
of dH2O. To prevent sample desiccation during imaging, 10 µL of simple M9 buffer was
evenly distributed throughout the agar pad. The simple M9 buffer was generated by
mixing 3 g of KH2PO4, 11.3 g of Na2HPO4•7H2O, 5 g of NaCl and 1 mL of 1 M MgSO4
to a final volume of 1 L dH2O. The M9 buffer was autoclaved and allowed to cool at
room temperature.
2.3 RNAi mediated depletion of proteins
RNA interference leads to depletion of protein levels by employing a genetically
modified feeder bacteria that expresses a double-stranded RNA (dsRNA). The dsRNA is
complementary to and targets the mRNA of the gene of interest for degradation. The
feeder bacteria possess an engineered plasmid containing the dsRNA specific to the gene
of interest under the control of an IPTG promoter. To generate engineered feeder
bacteria, single colonies obtained from frozen stocks maintained at -70° C were
suspended and shaken in liquid LB broth overnight at 37 C. To minimize contamination
in the overnight engineered feeder bacteria culture, ampicillin was added to a final
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concentration of 50 µg/mL of liquid LB broth. 250 µL of cultured feeder was seeded to
RNAi plates. The RNAi plates were prepared by combining 4.5 g NaCl, 25.5 g agar,
3.75 g peptone, 1.5 mL of 2 mg/mL uracil, 0.22 g CaCl2, and 0.75 ml of 10 mg/mL
cholesterol in 1463 mL of dH2O. After mixture was autoclaved and allowed to cool, 37.5
mL of phosphate buffer (pH 6), 1.5 mL of 1 M MgSO4, 1.5 mL of 1 M IPTG, 1.5 mL 25
mg/mL carbenicillin and 0.3 mL of 50 mg/mL ampicillin was added. Seeded RNAi plates
were dried at standard laboratory conditions for 24 hours. Upon assessment of various
RNAi exposure times (24, 48 and 72 hours), 48 hour exposure yielded optimal depletion
without proving fatal to the animal (data not shown). Therefore worms of similar age
were placed on seeded RNAi plates for 48 hours for all RNA interference experiments.
2.4 tunicamycin induced ER stress
Tunicamycin is an antibiotic that leads to ER stress by inhibiting N-linked glycosylation
in the ER, which leads to protein misfolding events. Studies across many organisms
show tunicamycin exposure is sufficient to trigger the ER specific UPR76. To induce a
UPR in adult nematodes and study embryonic effects, gravid worms were exposed to
tunicamycin isolated from Streptomyces lysosuperficus (Calibiochem) subsequent to 48
hour RNAi depletion. 10 mg of tunicamycin was dissolved in 1 mL of DMSO and stored
at -70 C. Tunicamycin plates were made by diluting the antibiotic to a final
concentration of 5 µg/mL of NGM. Plates were seeded with OP50 feeder bacteria and
allowed to dry in standard laboratory conditions for 24 hours. Preliminary data showed
48 hour tunicamycin exposure was optimal for assessing tunicamycin induced UPR.
Therefore worms were first exposed to 48 hour RNAi depletion and then moved and
maintained in the tunicamycin plates for 48 hours.
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2.5 Monitoring viability in ICD-1, ICD-2 and UNC-22 depleted adult worms under
tunicamycin
Three separate viability experiments were performed in worms containing an HSP4::GFP fusion protein (Caenorhabditis Genetics Center University of Minnesota SJ4005).
Viability was assessed in 30 gravid worms placed in tunicamycin plates subsequent to
ICD-1, ICD-2 and a control UNC-22 depletion. Worms were maintained in tunicamycin
plates for 48 hours at standard laboratory conditions and viable worms were counted
every 12 hours throughout the duration of the experiment. Worms were prodded for
movement with a heated platinum pick and samples displaying pharyngeal pumping as
well as mobility were considered viable.
2.6 Monitoring HSP-4 expression in ICD-1, ICD-2 and UNC-22 depleted live
embryos under tunicamycin
Three independent experiments were conducted to monitor HSP-4 expression and
localization in live embryos expressing an HSP-4::GFP fusion protein (cgc SJ4005). The
strain employed contains a zcIs4 reporter transgene inserted to chromosome V82. This
reporter transgene expresses an exogenous HSP-4 protein that is linked to a GFP
fluorophore and is unlinked to the intrinsic HSP-4 gene found on chromosome II.
Previous studies show the strain displays a strong GFP signal in gut and hypodermal cells
when subjected to heat stress or tunicamycin indicating its usefulness as a marker for ER
stress77. Worms from strain SJ4005 were moved to icd-1, icd-2 and a control unc-22
RNAi plates. 30 worms were maintained on each RNAi plates for 48 hours and were
then moved to tunicamycin plates for imaging. Worms were grown in the tunicamycin

20
plates at standard laboratory conditions for 48 hours. Imaging was performed at 12 hour
intervals throughout the duration of the experiment. During imaging intervals, randomly
picked embryos were mounted to glass microscope slides and viewed using the Z-stack
function of an inverted laser scanning confocal microscope (Nikon C1) at 60x
magnification. Laser excitation and digital image capturing conditions were comparable
in the three treatments to minimize variability amongst the generated Z-stacks.
2.6.1 Quantification of HSP-4 expression in ICD-1, ICD-2 and UNC-22 depleted live
embryos under tunicamycin
Fluorescent Z-stack 3-D images of live embryos expressing HSP-4 were captured with an
inverted laser scanning confocal microscope (Nikon C1). Images were captured using
laser scanning optical microscopy and analyzed with ImageJ software as established in
previous experiments78. Fluorescent intensity was measured with the Z-project
summation function. This function sums the pixel intensity of all of the stacks and
outputs a 2-D image representative of the fluorescence pixel intensity of the entire
embryo. To quantify pixel intensity in the summed 2-D image, embryos were outlined
and converted to 8-bit gray scale using the type submenu within the image menu. After
defining the entire embryo as the region of interest, average pixel intensity was obtained
using the measure tool within the analyze menu. This measurement outputs average
fluorescent intensity from each pixel within the region of interest. Quantification was
performed in 15-30 embryos for each imaging time interval.
2.6.2 Statistical analysis of HSP-4 expression in ICD-1, ICD-2 and UNC-22 depleted
live embryos
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Average pixel intensities from the three RNAi treatments under tunicamycin were
exported to Statistical Analysis Systems (SAS) software. To determine the presence of a
time-treatment effect, a repeated measures analysis of variance (ANOVA) was performed
as established in previous experimnts79. To find statistically significant differences
amongst treatments during each imaging interval, the repeated measures ANOVA was
followed by a LSD post-hoc analysis using a significance level α of 0.05.
2.7 Monitoring increased lysosomal content in ICD-1, ICD-2 and UNC-22 depleted
live embryos under tunicamycin
Three independent experiments were conducted to monitor increased lysosomal content
in live embryos. Lysosomal granules possess a naturally occurring autofluorescent
property when excited with an external fluorescence light source due to the protein and
lipid contents contained therein81. Unlike signal originating from artificially added
fluorophores, the natural light emission arises from intrinsic lysosomal properties and
may be captured using a blue fluorescent filter. Due to this innate biological property,
increased lysosomal content was assessed in progeny of worms from strain SJ4005. 30
gravid worms were fed icd-1, icd-2 and a control unc-22 RNAi for 48 hours. Following
RNAi treatment, worms were moved and maintained in tunicamycin plates for 48 hours.
Imaging was performed in 12 hour intervals throughout the duration of the experiment.
At each imaging interval, randomly picked embryos were mounted to microscope glass
slides and examined with a Zeiss Axioskop up-right fluorescence microscope at 100x
magnification using a blue fluorescence filter. External fluorescence power source
excitation and digital capturing conditions were comparable in the three treatments to
minimize variability amongst the generated images.
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2.7.1 Quantification of increased lysosomal content in ICD-1, ICD-2 and UNC-22
depleted live embryos under tunicamycin
2-D images of autofluorescing lysosomes in live embryos were captured with a Zeiss
Axioskop up-right fluorescence microscope. Images were captured using brightfield
optics and analyzed with ImageJ software. Pixel intensity quantification of the 2-D
images was comparable to HSP-4 expression quantification and was performed in 15-30
samples for each imaging time interval.
2.7.2 Statistical analysis of increased lysosomal content in ICD-1, ICD-2 and UNC22 live embryos
Average pixel intensities from the three RNAi treatments under tunicamycin were
exported to Statistical Analysis Systems (SAS) software. The data were subjected to
identical statistical analysis as HSP-4 expression.
2.8 Monitoring Fluorescence Recovery After Photobleaching (FRAP) under
tunicamycin
Fluorescence Recovery After Photobleaching (FRAP) was employed to assess the
embryos ability to reconstitute protein synthesis. The protocol and quantification
performed in all FRAP experiments were comparable to those of FRAP studies in live C.
elegans embryos80. In this technique, the fluorescent signal of cell specific markers is
photobleached using an external fluorescence power source and the recovery of novel
fluorescence signal is monitored over time to provide a direct measure of translation.
Three separate FRAP experiments were performed. Although methodologies and
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measurements were comparable, each experiment was performed using varying worm
strains (see below). For all FRAP experiments 30 gravid worms were maintained in icd1, icd-2 and a control unc-22 RNAi plates for 48 hours. Following 48 hour depletion,
worms were moved and maintained on tunicamycin plates for 12 hours. Photobleaching
was performed in 15-30 randomly picked embryos mounted to microscope glass slides
using a Zeiss Axioskop up-right fluorescence microscope at 100x magnification.
Fluorescent signal of individual embryos was extracted using an external fluorescence
power source for 4 minutes. Following photobleaching, embryos were imaged at 1, 2 and
5 hours post-photobleach to monitor recovery.
2.8.1 Neuronal Yellow Fluorescence Protein (NYFP) FRAP under tunicamycin
To examine neuronal cell’s ability to reconstitute protein synthesis under tunicamycin
stress, FRAP was performed in embryos containing a pan neuronal yellow fluorescence
protein marker driven by an unc-119 neuronal trafficking protein promoter (cgc
TU3310). Pan neuronal markers have multiple targets (somatic, nuclear, dendrites and
axons) and are consequently employed as global neuronal markers. In this experiment
worms were not subjected to RNAi depletion. However, adults were maintained in
tunicamycin plates for 12 hours and embryo imaging was performed during the
previously stated time intervals and imaging conditions. Untreated samples were
obtained from worms maintained in NGM plates containing DMSO only. External
fluorescence power source excitation and digital capturing conditions were comparable in
the three treatments to minimize variability amongst the generated images.
2.8.2 Gut Red Fluorescence Protein (GRFP) FRAP under tunicamycin
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To assess recovery of translation in gut cells under tunicamycin stress, FRAP was
performed in embryos expressing a peroxisomal targeting signal-1 (PTS1) RFP fusion
protein (cgc VS10). PTS1 is a ring finger protein required for import of peroxisomal
matrix proteins in gut cells, therefore the RFP signal is emitted from peroxisomes in the
intestinal cell lineage. Untreated samples were comparable to the NYFP FRAP under
tunicamycin. Imaging conditions and acquisition were performed as stated under
Monitoring Fluorescence Recovery After Photobleaching (FRAP) under tunicamycin.
External fluorescence power source excitation and digital capturing conditions were
comparable in the three treatments to minimize variability amongst the generated images.
2.8.3 Neuronal Yellow Fluorescence Protein (NYFP) FRAP in ICD-1 and ICD-2
depleted embryos under tunicamycin
FRAP was performed in NYFP embryos depleted of either ICD-1 or ICD-2 following 12
hour tunicamycin exposure to examine differences in protein synthesis recovery in the
presence of either subunit. Imaging conditions and acquisition were performed as stated
under Monitoring Fluorescence Recovery After Photobleaching (FRAP) under
tunicamycin. External fluorescence power source excitation and digital capturing
conditions were comparable in the three treatments to minimize variability amongst the
generated images.
2.8.4 Quantification of Fluorescence Recovery After Photobleaching (FRAP) under
tunicamycin
2-D fluorescence images of live embryos during recovery were captured with a Zeiss
Axioskop up-rights fluorescence microscope. Images were captured using brightfield
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optics and analyzed with ImageJ software. The protocol for pixel intensity quantification
of the 2-D images was identical to HSP-4 expression quantification and was performed in
20-30 samples for each imaging time interval.
2.8.5 Statistical analysis of Fluorescence Recovery After Photobleaching (FRAP)
under tunicamycin
The average pixel intensities generated from the FRAP images were exported to excel. A
simple regression model was generated to determine the degree of correlation (R2)
amongst fluorescent signal recovery over time in the three FRAP experiments as
previously established80.
2.9 Monitoring NYFP and GRFP expression in ICD-1, ICD-2 and UNC-22 depleted
live embryos under tunicamycin
Three independent experiments were conducted to monitor NYFP and GRFP expression
as well as localization in live embryos expressing a unc-119::YFP (cgc TU3310) and
PTS1::RFP (cgc VS10) fusion proteins, respectively83, 84. Experimental conditions,
parameters and image acquisition performed was comparable to the above stated
Monitoring HSP-4 expression in ICD-1, ICD-2 and UNC-22 depleted live embryos under
tunicamycin . However, imaging was performed in live embryos from the three RNAi
treatments at 12 and 24 hour tunicamycin exposure. Laser excitation and digital image
capturing conditions were comparable in the three treatments to minimize variability
amongst the generated Z-stacks.
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2.9.1 Quantification of NYFP and GRFP expression in ICD-1, ICD-2 and UNC-22
depleted live embryos under tunicamycin
Fluorescent Z-stack 3-D images of live embryos were captured with a Nikon C1 inverted
laser scanning confocal microscope. Images were captured using laser scanning optical
microscopy and analyzed using the Z-project summation function of the ImageJ software
as previously established78. Fluorescent intensity of the summed 2-D images was
quantified as previously stated under Quantification of HSP-4 expression in ICD-1, ICD2 and UNC-22 depleted live embryos under tunicamycin and was performed in 15-30
samples for each imaging time interval.
2.9.2 Statistical analysis of NYFP and GRFP expression in ICD-1, ICD-2 and UNC22 depleted live embryos under tunicamycin
Average pixel intensities of the three RNAi treatments under tunicamycin generated from
the NYFP and GRFP summed images were exported to Statistical Analysis Systems
(SAS) software. The pooled data from the experiments conducted in the two strains were
subjected to identical statistical analysis as HSP-4 expression79.

3 Results
3.1 effect of tunicamycin exposure on adult worm viability
Exposure to tunicamycin, an antibiotic isolated from Streptomyces, elicits an ERspecific UPR by inhibiting N-linked glycosylation of proteins being processed for
secretion or membrane localization. Previous experiments show that, relative to ICD-1
depletion, ICD-2 depleted adult worms are more resistant to heat stress as measured by
survival62. To determine whether worms depleted of ICD-1 or ICD-2 display altered
viability under sustained ER stress, survival of adult nematodes exposed to tunicamycin
was measured in samples depleted of either protein subunit as well as a control treatment.
Interestingly, a greater proportion of ICD-1 depleted worms were more resistant to death
in the presence of tunicamycin relative to ICD-2 and UNC-22 depleted worms throughout
the length of the experiment. In addition, icd-2 and unc-22 RNAi treatments displayed
virtually equal proportions of viable nematodes during 24 and 36 hour tunicamycin
exposures (Figure 1).
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Figure 1: Proportion of alive adult C. elegans under tunicamycin exposure
following icd-1, icd-2 and unc-22 RNAi. Gravid adults were exposed to tunicamycin
for a duration of 48 hours. Viability was measured every 12 hours by pharyngeal
pumping in response to prodding with a heated platinum pick. Treatment worms were
maintained in RNAi plates for 48 hours prior to tunicamycin exposure (n = 20-30
adults for each measured time point).
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3.2 ICD-1 depletion leads to greater induction of HSP-4 chaperone expression
relative to ICD-2 and UNC-22 depletion during sustained ER stress
Independent studies, employing distinct model systems, show that depletion of
either NAC subunit is sufficient to activate the ER specific UPR62, 63. To determine
whether the increased viability of ICD-1 depleted worms in the presence of tunicamycin
was a result of ER specific chaperone up-regulation, HSP-4 levels were monitored in
embryos obtained from adults fed icd-1, icd-2 or unc-22 RNAi for 48 hours prior to
tunicamycin exposure for 12 and 24 hours. Given that HSP-4 is the C. elegans
homologue of the mammalian ER chaperone BiP, an HSP-4::GFP reporter strain was
employed to quantify ER specific chaperone levels (see methods).
At 12 hour tunicamycin exposure, ICD-1 depleted embryos displayed a large
increase in HSP-4::GFP reporter expression compared to ICD-2 or UNC-22 depleted
embryos. Furthermore, the majority of the signal in ICD-1 depleted embryos was
localized to the anterior portion of the embryo where most cells are of neuronal lineage.
ICD-2 and UNC-22 depleted embryos displayed similar HSP-4::GFP localization, with
weak expression at the anterior portion of the embryo. The neuronal HSP-4::GFP
expression obtained in all RNAi experimental populations when exposed to tunicamycin
was absent in untreated wild-type embryos (Figure 2 A.)
24 hour tunicamycin exposure also led to a large increase in HSP-4::GFP reporter
expression in ICD-1 depleted embryos relative to ICD-2 or UNC-22 depleted embryos.
However, the HSP-4::GFP signal in ICD-1 depleted embryos expanded from the anterior
portion of the embryo to the posterior region during the 24 hour tunicamycin-imaging
interval. Similarly, the ICD-2 and UNC-22 depleted embryos displayed a stronger,
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diffused, HSP-4::GFP expression in the posterior region that was absent during 12 hour
tunicamycin exposure in these experimental treatments. However, only UNC-22
depleted embryos depicted an increase in HSP-4::GFP expression levels from 12 hour to
24 hour tunicamycin exposure in the anterior region. The HSP-4::GFP expression levels
in ICD-2 depleted embryos seemed virtually unaltered in the anterior portion with
prolonged tunicamycin exposure (Figure 2 B.).
To compare the HSP-4::GFP signal strength of ICD-1, ICD-2 and UNC-22
depleted embryos during 12 and 24 hour tunicamycin exposure, the fluorescent intensity
of randomly picked embryos from each respective experimental population was
quantified. Although all experimental populations displayed an increase in HSP-4::GFP
signal relative to untreated embryos (- tunicamycin), RNAi treatment specific differences
were observed at both 12 and 24 hour tunicamycin exposure. On average, the HSP4::GFP fluorescent intensity at 12 hour tunicamycin exposure in ICD-1 depleted embryos
was 4 times greater than ICD-2 depleted embryos and 1.5 times greater than control
embryos (Figure 3). Given that a repeated measures ANOVA yielded a significant time
and treatment difference (P < 0.05), an LSD and Tukey post-hoc analysis was performed.
The LSD analysis minimizes type-2 error rate whereas Tukey analysis minimizes type-1
error rate. For 12 hour tunicamycin exposure, LSD analysis revealed all averages where
significantly different from each other (P < 0.05). However, the results from a more
conservative Tukey analysis showed the average fluorescent intensity in ICD-2 depleted
embryos was significantly lower than the average fluorescent intensity of ICD-1 depleted
embryos and control embryos, which were not significantly different from each other (P
< 0.05) (Figure 3). Consistent with the signal strength pattern obtained at 12 hour
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tunicamycin exposure, the average fluorescent intensity was strongest in ICD-1 depleted
embryos followed by controls and lowest in ICD-2 depleted embryos. Overall, there was
an increase in average fluorescent intensity in all treatments with sustained tunicamycin
exposure. On average, the HSP-4::GFP fluorescence intensity at 24 hour tunicamycin
exposure in ICD-1 depleted embryos was 3.5 times greater than ICD-2 depleted embryos
and 2 times greater than control embryos. During 24 hour tunicamycin exposure, the
results from both LSD and Tukey post-hoc analysis showed the average fluorescent
intensity in ICD-1 depleted embryos was significantly higher than the average fluorescent
intensity of ICD-2 depleted embryos and controls, which were not significantly different
each other (P < 0.05) (Figure 3).
To further characterize the differences in the localization of HSP-4::GFP
expression, ICD-1 and ICD-2 depleted embryos subjected to 24 hour tunicamycin
exposure were carefully examined under oil immersion. The ICD-2 depleted embryos
depicted a diffuse signal throughout the embryo along with a portion of the signal
distinctly originating from lysosomal structures. ICD-1 depleted embryos contained a
diffuse signal in the entirety of the embryo but lacked any distinct signal emerging from
lysosomal structures within the embryo (Figure 4). Therefore at 12 and 24 hour
tunicamycin exposure, ICD-1 and ICD-2 depleted embryos varied in HSP-4::GFP
localization, abundance and source of signal.
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Figure 2: 3D projection of HSP-4::GFP expression in icd-1, icd-2 or unc-22 RNAi
treated adults exposed to tunicamycin as well as untreated samples. Images were
acquired under 60x magnification and identical exposure settings using a Nikon C1
inverted laser scanning confocal microscope. 3D projections were generated using the
Z-project summation tool in ImageJ. Following 48 hour icd-1, icd-2 or unc-22 RNAi,
parental worms were exposed to tunicamycin. Randomly picked embryos from each
RNAi experimental population under tunicamycin were mounted on agar pads and
imaged at 12 hour tunicamycin exposure (Images on column A) as well as 24 hour
tunicamycin exposure (Images on column B). Untreated embryos were also imaged for
comparison (Image A and B). Embryos in images A and B were genetically identical,
containing an HSP-4::GFP reporter construct (cgc SJ4005).
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Figure 3: Quantified average HSP-4::GFP fluorescent intensity of whole embryos
obtained from icd-1, icd-2 and unc-22 RNAi treated adults exposed to
tunicamycin. The HSP-4::GFP fluorescent intensity of 3D projections generated
from icd-1, icd-2 and unc-22 depleted embryos during 12 and 24 hour tunicamycin
exposure was quantified using the Z-project summation function in ImageJ. Each bar
represents the average pixel intensity (AU) for all embryos in each experimental
population. The error bars represent standard error for each average pixel intensity. A
repeated measures ANOVA followed by a LSD and Tukey post-hoc analysis was
performed using SAS. * denotes significant difference of P < 0.05 for LSD analysis
and * denotes significant difference of P < 0.05 for Tukey analysis. Average HSP4::GFP pixel intensity of untreated embryos (- tunicamycin) was also presented for
comparison to basal signal strength (n = 15-30 embryos for each measured time point).
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Figure 4: Comparison of HSP-4::GFP signal source in ICD-1 and ICD-2
depleted embryos during tunicamycin exposure. Images were acquired
under 100x magnification and identical exposure settings using a Zeiss
Axioskop up-right fluorescence microscope. Following 48 hour ICD-1 or
ICD-2 depletion, parental worms were exposed to 24 hour tunicamycin.
Randomly picked embryos from the icd-1 RNAi (A.) and icd-2 RNAi (B.)
experimental population under tunicamycin were mounted on agar pads and
imaged at 24 hour tunicamycin exposure.
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3.3 ICD-1, ICD-2 and UNC-22 depletion leads to equivalent levels of lysosomal
presence during sustained ER stress
After confirming that HSP-4::GFP expression was significantly higher in ICD-1
depleted embryos relative to ICD-2 depleted embryos exposed to tunicamycin,
differences in lysosomal presence were assessed to determine whether the observed
increase in UPR activity leads to an increase in protein turnover in ICD-1, ICD-2 or
UNC-22 depleted embryos under tunicamycin. Lysosomal granules possess a naturally
occurring autofluorescent property when excited with a blue fluorescence light source
due to the protein and lipid contents contained within the lysosome. Due to this innate
biological property, differences in lysosomal presence were able to be assessed in the
progeny of adults containing an HSP-4::GFP reporter. Adult nematodes were fed icd-1,
icd-2 or unc-22 RNAi for 48 hours prior to tunicamycin exposure for 12 and 24 hours.
All of the RNAi experimental populations exhibited a minor qualitative increase in the
abundance, size and localization of the auto fluorescent lysosomal granules relative to
untreated samples during both 12 and 24 hour tunicamycin exposure (data not shown).
Given that the differences in increased lysosomal generation appeared to be
negligible between treatment populations while qualitatively different when compared to
untreated, the autofluorescent lysosomal intensity of randomly picked embryos from each
respective experimental population was quantified and compared to untreated. The
average auto fluorescent lysosomal pixel intensity appeared to increase in ICD-1 and
ICD-2 depleted embryos relative to untreated samples during 12 hour tunicamycin
exposure. In contrast, UNC-22 depleted embryos failed to display an increased
lysosomal generation during 12 hour tunicamycin exposure. On average, after 24 hours
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of tunicamycin exposure, all RNAi treatments appeared to display an increased lysosomal
generation relative to basal autofluorescent lysosomal pixel intensity. However, results
from a repeated measures ANOVA revealed there were no significant differences in
increased lysosomal generation between ICD-1, ICD-2 or UNC-22 depleted embryos
during 12 and 24 hour tunicamycin exposure (P > 0.05) (Figure 5).
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Figure 5: Quantified average Lysosomal autofluorescent intensity of whole
embryos obtained from icd-1, icd-2 and unc-22 RNAi treated adults exposed to
tunicamycin. The auto fluorescent lysosomal intensity of single plane images from
ICD-1, ICD-2 and UNC-22 depleted embryos during 12 and 24 hour tunicamycin
exposure were quantified using ImageJ. Each bar represents the average pixel
intensity (AU) for all embryos in each experimental population. The error bars
represent standard error for each average pixel intensity. Average auto fluorescent
lysosomal pixel intensity of untreated embryos (- tunicamycin) was also presented for
comparison to basal signal strength (n = 15-30 embryos for each measured time point).
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3.4 ICD-1-depleted embryos display a more robust attenuation of protein synthesis
compared to ICD-2-depleted embryos during ER stress
Although neither ICD-1 nor ICD-2 depleted embryos under ER stress failed to
show significant differences in lysosomal presence (Figure 5), statistical analysis showed
ICD-1-depleted embryos exhibited a greater HSP-4::GFP signal during 12 and 24 hour
tunicamycin exposure compared to ICD-2-depleted embryos under similar stress (Figure
3). Based on the results obtained after assessing two major UPR outcomes, fluorescence
recovery after photo bleaching (FRAP) was employed to explore levels of protein
synthesis attenuation during ER stress, another important cell-saving stress response. An
advantage in this procedure is the presence of cell-type specific fluorescent proteins that
allowed for FRAP to be conducted in transgenic embryos expressing a pan neuronal
yellow fluorescent protein (YFP) (TU3310) as well as embryos expressing a gut cell red
fluorescent protein (RFP). In these embryos, FRAP was performed in ICD-1 or ICD-2
depleted populations under ER stress to correlate differences in protein production with
varying levels of α or βNAC. Embryos were acquired from adult worms subjected to 12
hour tunicamycin exposure, previously established as sufficient to elicit an increase in
HSP-4::GFP levels in all RNAi treatments relative to untreated embryos (figure 3).
In the – tunicamycin and + tunicamycin neuronal YFP experimental populations,
a 4 minute photo bleach was sufficient to eliminate any detectable signal (Figure 6).
Following a 5 hour recovery, untreated samples displayed a diffuse YFP signal
throughout the entire embryo (Figure 6A). However, the neuronal YFP signal in the
tunicamycin -treated embryos appeared to originate solely from a specific region of the
embryo that will eventually give rise to the head portion of the adult worm (Figure 6B).
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To confirm the apparent difference in recovery amongst the two samples, YFP pixel
intensities were quantified for each treatment at specified time points throughout the
duration of the experiment and a regression analysis of the average pixel intensities over
time was performed. Tunicamycin -treated samples retained relatively equal YFP
average pixel intensities throughout the recovery period and failed to reconstitute prephoto bleach average pixel intensity (Figure 7A). Untreated samples displayed a gradual
increase in YFP average pixel intensity during the recovery period but also failed to reach
the initial average pixel intensity (Figure 7A). The regression analysis revealed a strong
positive linear trend in signal recovery over time in the untreated samples, which was
absent in the tunicamycin treated samples (Figure 7B).
Like both neuronal YFP populations, 4 minutes of photo bleaching eliminated any
detectable signal in gut cell RFP embryos (Figure 8). Unlike the neuronal YFP embryos,
both treated and untreated embryos displayed virtually equal gut cell RFP expression
patterns following a 5 hour recovery (Figure 8). Quantified RFP pixel intensity showed
both treatments almost reached their respective initial pre-photo bleach average pixel
intensity following a 1 hour recovery (Figure 9A). Furthermore, a 5 hour recovery period
led to virtually identical average pixel intensities in both treated and untreated samples
(Figure 9A.) A regression analysis of the quantified GRFP average pixel intensity
revealed both GRFP sample populations displayed similar linear trends in signal recovery
throughout the recovery period (Figure 9B.).
After characterizing protein synthesis changes in two stressed nematode strains
containing cell specific markers and fully functional NAC, attenuation of protein
synthesis during ER stress was assessed in neuronal YFP transgenic embryos depleted of

40
either ICD-1 or ICD-2. In ICD-1 or ICD-2 depleted embryos exposed to tunicamycin
(12 hours), a 4 minute photo bleach successfully reduced initial YFP pixel intensity levels
(Figure 10). Although ICD-1 and ICD-2 depleted embryos were subjected to identical
tunicamycin exposure times, the two sample populations displayed distinct YFP signal
expression patterns; the neuronal marker signal in ICD-1 depleted embryos appeared
confined to a specific region of the embryo, whereas ICD-2 defective embryos displayed
a diffuse YFP signal throughout the entire embryo along with some signal confined to the
similar region observed with ICD-1 depletion (Figure 10). To reinforce this striking
observation, a regression analysis of the quantified neuronal YFP average pixel
intensities throughout the recovery period was performed. Consistent with previous
results, tunicamycin -treated ICD-1 defective embryos retained relatively equal YFP
average pixel intensities throughout the recovery period and failed to reconstitute initial
average pixel intensity (Figure 11A.). Alternatively, tunicamycin -treated ICD-2
defective embryos portrayed a gradual increase in YFP average pixel intensities
throughout the recovery period and reached nearly equal pre-photo bleach average pixel
intensity (Figure 11A.). In addition, a regression analysis revealed the rate of protein
synthesis was quicker with ICD-2 depletion relative to ICD-1 depletion (Figure 11B).
Therefore, in the presence of ER stress, ICD-2 depleted embryos interestingly mimicked
the FRAP profile of untreated neuronal YFP embryos while YFP recovery in ICD-1
depleted embryos was consistent with tunicamycin-treated neuronal YFP embryos.
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Figure 6: Comparison of pan neuronal YFP FRAP recovery profile in tunicamycin
treated and untreated embryos. Images were acquired under 100x magnification
and identical exposure settings using a Zeiss Axioskop up-right fluorescence
microscope. Untreated samples were obtained from worms maintained in NGM plates
containing DMSO only (A). tunicamycin treated samples were subjected to a 12 hour
stress period (B). Embryos were mounted on agar pads at each imaging interval.
Fluorescent signal of individual embryos was extracted using an external fluorescence
power source for a duration of 4 minutes. Following photo bleaching, recovery was
monitored by imaging embryos at 1, 2 and 5 hours post-photo bleach. Embryos in
images A and B were genetically identical, containing pan neuronal YFP reporter
construct (cgc TU3310).
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Figure 7: Quantification and regression analysis of pan neuronal YFP recovery in
tunicamycin treated and untreated embryos. NYFP pixel intensity of single plane
images from untreated and 12 hour tunicamycin treated embryos was quantified using
ImageJ. Each bar represents the average pixel intensity (AU) during each imaging
interval and error bars represent standard error for each average pixel intensity (Image
A). A regression analysis of the average pixel intensity during each imaging interval
was performed using Microsoft excel (Image B) (n = 15-30 embryos for each measured
time point).
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Figure 8: Comparison of gut cell RFP FRAP recovery profile in tunicamycin
treated and untreated embryos. Images were acquired under 100x magnification
and identical exposure settings using a Zeiss Axioskop up-right fluorescence
microscope. Untreated samples were obtained from worms maintained in NGM
plates containing DMSO only (A). Tunicamycin treated samples were subjected to a
12 hour stress period (B). Embryos were mounted on agar pads at each imaging
interval. Fluorescent signal of individual embryos was extracted using an external
fluorescence power source for a duration of 4 minutes. Following photo bleaching,
recovery was monitored by imaging embryos at 1, 2 and 5 hours post-photo bleach.
Embryos in images A and B were genetically identical, containing gut cell specific
peroxisomal RFP reporter construct (cgc VS10).
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Figure 9: Quantification and regression analysis of gut cell RFP recovery
in tunicamycin treated and untreated embryos. GRFP pixel intensity of
single plane images from untreated and 12 hour tunicamycin treated embryos
was quantified using ImageJ. Each bar represents the average pixel intensity
(AU) during each imaging interval and error bars represent standard error for
each average pixel intensity (A). A regression analysis of the average pixel
intensity during each imaging interval was performed using Microsoft excel
(B) (n = 15-30 embryos for each measured time point).
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Figure 10: Comparison of pan neuronal YFP FRAP recovery profile in ICD-1
or ICD-2 depleted embryos exposed to tunicamycin. Images were acquired
under 100x magnification and identical exposure settings using a Zeiss Axioskop
up-right fluorescence microscope. Following 48 hour ICD-1 or iICD-2 depletion,
embryos were subjected to 12 hour tunicamycin exposure. Embryos were
mounted on agar pads at each imaging interval. Randomly picked embryos
depleted of either ICD-1 (Image A) or ICD-2 (Image B) were mounted on agar
pads and imaged at 12 hour tunicamycin exposure. Embryos in images A and B
were genetically identical, containing pan neuronal YFP reporter construct (cgc
TU3310).
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Figure 11: Quantification and regression analysis pan neuronal YFP FRAP
recovery profile in ICD-1 or ICD-2 depleted embryos exposed to
tunicamycin. NYFP pixel intensity of single plane images from ICD-1 or ICD-2
depleted embryos subjected to 12 hour tunicamycin exposure was quantified
using ImageJ. Each bar represents the average pixel intensity (AU) during each
imaging interval and error bars represent standard error for each average pixel
intensity (Image A). A regression analysis of the average pixel intensity during
each imaging interval was performed using Microsoft excel (Image B) (n = 1530 embryos for each measured time point).
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3.5 Tunicamycin exposure reduces expression of a global neuronal marker in ICD-1
depleted embryos relative to ICD-2 depleted and control embryos
Independent studies in a variety of systems suggest αNAC and the UPR may
contribute to cellular homeostasis; in some cases, disruption to either αNAC or the UPR
function leads to altered cellular differentiation in similar cell types68-74. To test whether
altered levels of icd-1 or icd-2 during ER stress affects neuronal development, expression
of a pan neuronal marker was monitored and quantified in ICD-1, ICD-2 or UNC-22
depleted embryos under ER stress. Samples were classified as either early stage or late
stage embryos to minimize developmental stage specific variation. Average neuronal
YFP pixel intensity in early embryos was lower for all RNAi sample populations at 12
and 24 hour tunicamycin exposure compared to basal YFP average pixel intensity (Figure
12). A repeated measures ANOVA, followed by a LSD post-hoc analysis, revealed YFP
average pixel intensity in ICD-1 depleted early embryos was significantly lower at 24
hour tunicamycin exposure relative to ICD-2 and UNC-22 defective early embryos (P <
0.05) (Figure 12). As expected, the majority of the signal in untreated early-stage
embryos was diffuse and originated anteriorly in a region populated by neurons (figure
13). During 24 hour tunicamycin exposure, neuronal YFP expression in ICD-2 and
UNC-22 depleted early embryos was comparable to untreated embryos. However,
neuronal YFP expression in ICD-1 defective early embryos appeared weaker, punctate
and localized to specific neurons in the embryo (Figure 13).
The neuronal YFP signal intensity trend observed in late embryos subjected to ER
stress was comparable to early embryos. In late embryos, 12 and 24 hour tunicamycin
exposure also led to a decreased average YFP pixel intensity in all RNAi sample
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populations relative to untreated YFP average pixel intensity (Figure 14). Furthermore,
statistical analysis showed YFP average pixel intensity was significantly lower in ICD-1
depleted late-stage embryos at 12 hour tunicamycin exposure relative to ICD-2 and UNC22 depleted late-stage embryos (P < 0.05) (Figure 14). In untreated late embryos,
neuronal YFP expression appeared primarily diffused with some signal concentrated at a
specific region of the embryo. During 12 hour tunicamycin exposure, YFP expression in
ICD-1 depleted embryos was strikingly confined to specific neurons whereas ICD-2 and
UNC-22 depleted samples appeared to mimic homeostatic NYFP expression (Figure 15).
Tunicamycin exposure decreased NYFP pixel intensity in all RNAi samples with ICD-1
depleted late and early embryos displaying the greatest decrease at 12 and 24 hour,
respectively.
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Figure 12: Quantified average pan neuronal YFP fluorescent intensity in early
embryos obtained from icd-1, icd-2 and unc-22 RNAi treated adults exposed to
tunicamycin. The NYFP fluorescent intensity of 3D projections generated from ICD1, ICD-2 and UNC-22 depleted early embryos during 12 and 24 hour tunicamycin
exposure was quantified using the Z-project summation function in ImageJ. Each bar
represents the average pixel intensity (AU) for all early embryos in each experimental
population. The error bars represent standard error for each average pixel intensity. A
repeated measures ANOVA followed by a LSD and Tukey post-hoc analysis was
performed using SAS. * denotes significant difference of P < 0.05 for LSD analysis
and * denotes significant difference of P < 0.05 for Tukey analysis. Average NYFP
pixel intensity of untreated early embryos (- tunicamycin) was also presented for
comparison to basal signal strength (n = 15-30 embryos for each measured time point).
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Figure 13: 3D projection of pan neuronal YFP expression in icd-1, icd-2 or unc22 RNAi depleted early embryos exposed to tunicamycin as well as untreated
samples. Images were acquired under 60x magnification and identical exposure
settings using a Nikon C1 inverted laser scanning confocal microscope. 3D
projections were generated using the Z-project summation tool in ImageJ.
Following 48 hour icd-1, icd-2 or unc-22 RNAi, parental worms were exposed to
tunicamycin. Randomly picked early embryos from each RNAi experimental
population under tunicamycin were mounted on agar pads and imaged at 24 hour
tunicamycin exposure. Untreated early embryos were also imaged for comparison.
All embryos were genetically identical, containing a pan neuronal YFP reporter
construct (cgc SJ4005)
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Figure 14: Quantified average pan neuronal YFP fluorescent intensity in late
embryos obtained from icd-1, icd-2 and unc-22 RNAi treated adults exposed to
tunicamycin. The NYFP fluorescent intensity of 3D projections generated from ICD1, ICD-2 and UNC-22 depleted late embryos during 12 and 24 hour tunicamycin
exposure was quantified using the Z-project summation function in ImageJ. Each bar
represents the average pixel intensity (AU) for all late embryos in each experimental
population. The error bars represent standard error for each average pixel intensity. A
repeated measures ANOVA followed by a LSD and Tukey post-hoc analysis was
performed using SAS. * denotes significant difference of P < 0.05 for LSD analysis
and * denotes significant difference of P < 0.05 for Tukey analysis. Average NYFP
pixel intensity of untreated late embryos (- tunicamycin) was also presented for
comparison to basal signal strength (n = 15-30 embryos for each measured time point).
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Figure 15: 3D projection of pan neuronal YFP expression in icd-1, icd-2 or unc-22
RNAi depleted late embryos exposed to tunicamycin as well as untreated
samples. Images were acquired under 60x magnification and identical exposure
settings using a Nikon C1 inverted laser scanning confocal microscope. 3D
projections were generated using the Z-project summation tool in ImageJ. Following
48 hour icd-1, icd-2 or unc-22 RNAi, parental worms were exposed to tunicamycin.
Randomly picked late embryos from each RNAi experimental population under
tunicamycin were mounted on agar pads and imaged at 12 hour tunicamycin exposure.
Untreated late embryos were also imaged for comparison. All embryos were
genetically identical, containing a pan neuronal YFP reporter construct (cgc SJ4005).
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3.6 Tunicamycin exposure leads to equivalent expression levels of a gut cell marker
in ICD-1, ICD-2 and UNC-22 depleted embryos
After finding significant differences in the expression of the specific neuronal
marker employed, expression of a gut cell marker (cgc VS10) was monitored and
quantified in ICD-1, ICD-2 or UNC-22 depleted embryos exposed to tunicamycin.
Samples were classified into either early-stage or late-stage embryos to minimize age
specific variation. 12 and 24 hour tunicamycin exposure resulted in increased gut cell
RFP pixel intensity for all RNAi treatments compared to basal expression. Although
ICD-1 and ICD-2 depleted early embryos depicted a gradual increase in average RFP
pixel intensity, UNC-22 defective early embryos displayed a decrease in average RFP
pixel intensity with sustained tunicamycin exposure. A repeated measures ANOVA
showed there were no significant time and treatment differences in early-stage embryo
gut cell RFP average pixel intensity (P < 0.05) (Figure 16). In late-stage embryos, the gut
cell RFP average pixel intensities of all RNAi samples during 12 hour tunicamycin
exposure was virtually equal to the average pixel intensity of untreated embryos.
However, 24 hour tunicamycin exposure appeared to increase in the RFP average pixel
intensity of all RNAi depleted late-stage embryos compared to untreated embryos. A
repeated measures ANOVA showed there were no significant time and treatment
differences in late-stage embryo gut cell RFP average pixel intensity (P < 0.05) (Figure
17).
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Figure 16: Quantified average gut cell RFP fluorescent intensity in early embryos
obtained from icd-1, icd-22 and unc-22 RNAi treated adults exposed to
tunicamycin. The GRFP fluorescent intensity of 3D projections generated from ICDICD
1, ICD-2 and UNC-22
22 depleted early embryos during 12 and 24 hour tunicamycin
exposure was quantified using the Z
Z-project summation
tion function in ImageJ. Each bar
represents the average pixel intensity (AU) for all early embryos in each experimental
population. The error bars represent standard error for each average pixel intensity.
Average GRFP pixel intensity of untreated earl
early embryos (- tunicamycin) was also
presented for comparison to basal signal strength (n = 15
15-30
30 embryos for each
measured time point).
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Figure 17: Quantified average gut cell RFP fluorescent intensity in late embryos
obtained from icd-1, icd-22 and unc-22 RNAi treated adults exposed to
tunicamycin. The GRFP fluorescent intensity of 3D projections generated from ICDICD
1, ICD-2 and UNC-22
22 depleted late embryos during 12 and 24 hour tunicamycin
exposure was quantified using the Z
Z-project summation function in ImageJ. Each bar
represents the average pixel intensity (AU) for all late embryos in each experimental
population. The error bars represent standard error for each average pixel intensity.
Average GRFP pixel intensity of untreated late embryos (- tunicamycin) was also
presented for comparison to basal signal strength (n = 15
15-30
30 embryos for each
measured time point).

4 Discussion
The presence of a wide range of environmental stimuli (chemical agents, hypoxia,
heat, inappropriate protein translocation and alterations to protein metabolism) is
sufficient to induce misfolded protein stress in cells1, 2. If induced, cells possess various
misfolded protein stress coping mechanisms responsible for restoring cellular integrity
and maintaining proper functionality3, 4. In certain cases cells fail to resolve stress and
trigger apoptosis resulting in the loss of cell function. Alternatively, an exaggerated
protective response may cause highly damaged cells to evade apoptosis and become
dangerous to the organism. Therefore misfolded protein stress responses become
determinants of the “tipping point” between cell survival and death9, 10. In fact, various
diseases have been causally associated with alterations in stress response function11, 12. In
this context, the ER-specific UPR is a major contributor to the “tipping point” between
cell survival and death during misfolded protein stress. The UPR elicits cell saving
responses, e.g. increased expression of ER specific chaperones, attenuation of protein
synthesis and increased protein turnover and ultimately cell killing responses, e.g.
apoptosis as a function of the duration of misfolded protein stress24-27. Based on the
importance and complexity of UPR activity, an understanding of factors that affect UPR
activity will provide further insights into cellular responses in the presence of misfolded
protein stress.
4.1 tunicamycin exposure leads to differences in ER specific chaperone expression,
translation attenuation but not lysosomal presence in ICD-1 or ICD-2 depleted
embryos
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The heterodimeric NAC complex is hypothesized to regulate protein shuttling into
the ER49, 52, 53, 56. Based on this model, disruption of the NAC may induce misfolded
protein stress due to inappropriate protein localization to the ER, and therefore activate
the UPR. Consistent with this model, removal of either α- or βNAC leads to the
expression of several markers associated with an active UPR62, 63. Therefore, as a
complex it is clear the NAC regulates protein homeostasis in the ER. However, studies
suggest the individual subunits possess independent functions above and beyond the roles
they play in complex with each other57, 58. As such, depletion of one subunit of the NAC
could lead to a two-pronged engagement of the UPR: loss of NAC function initiating the
UPR in addition to initiation of specific elements of the UPR by the subunit in relative
excess in the cell. To test this hypothesis, differences in UPR outcomes were assessed in
organisms depleted of either α- or β-NAC. The specific UPR outcomes assessed were:
(1) increased expression of ER-specific chaperone, (2) attenuation of protein synthesis
and (3) lysosomal presence as an indirect measure of protein turnover.
A previously proposed model assumes that eliminating NAC functionality, by
removal of either α- or β-NAC, engages the UPR only by disrupting the routing of
proteins to the ER. If true, removal of either NAC subunit would be expected to yield
equivalent results with regards to stress-induced UPR outcomes, including the up
regulation of ER specific chaperones. Quantification of total embryonic HSP-4::GFP
showed tunicamycin treatment led to an increase from basal levels at 12 and 24 hour
tunicamycin exposure (Figure 3), likely a result of expression in neurons as HSP-4 signal
was absent in the neuronal region of untreated embryos (Figure 2). HSP-4::GFP pixel
intensity was higher in ICD-1 depleted embryos compared to ICD-2 defective embryos at
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12 and 24 hour tunicamycin exposure (Figure 3). Furthermore, some lysosomal HSP-4
signal was observed in ICD-2 depleted embryos, which was absent in ICD-1 depleted
embryos (Figure 4). This observation reveals a striking difference in the source of the
signal that may contribute to the resulting differences in HSP-4::GFP levels with
depletion of either subunit. Initial HSP-4::GFP levels in samples depleted of either ICD1 or ICD-2 may account for the variation in ER specific chaperones once tunicamycin generated ER stress is present. Compared to ICD-2 depletion, ICD-1 depletion may lead
to greater initial HSP-4::GFP up regulation that becomes augmented when exposed to
tunicamycin. Although previous studies show that in the absence of exogenous stress
ICD-1 depleted embryos up-regulate HSP-4::GFP compared to wild-type embryos62, an
experiment must be performed to determine whether average HSP-4::GFP levels are in
fact greater in ICD-1 depleted embryos compared to ICD-2 defective embryos before the
addition of tunicamycin.
Results using FRAP in C. elegans embryos showed 12 hour tunicamycin exposure
was sufficient to suppress the recovery of a fluorescent neuronal marker (Figure 7) but
not of a gut cell marker (Figure 9). A functional NAC is known to promote translation57;
removal of either subunit would be predicted to yield an equal attenuation of protein
synthesis under stress if individual subunit function had no effect on this outcome.
Comparison of neuronal FRAP recovery profiles between ICD-1 and ICD-2-depleted
embryos showed ICD-1 depletion led to a stronger suppression of protein synthesis
during tunicamycin -mediated stress (Figure 11). In the presence of misfolded protein
stress, the UPR suppresses translation to prevent cells from reaching proteotoxicity by
sequestering GRP78/BiP away from PERK30, 31. Therefore GRP78/BiP levels are an
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indicative of the extent to which UPR-mediated translation attenuation is engaged. In
this context, the variation in translation attenuation observed between ICD-1 and ICD-2
depleted embryos may be a function of the extent to which the UPR was engaged as
measured by HSP-4 levels, the C. elegans GRP78/BiP homologue. The relatively faster
recovery of protein synthesis observed in ICD-2 depleted embryos antagonizes the
protective UPR response and is likely a reflection of the weak increase in HSP-4::GFP
during 12 hour tunicamycin exposure. Alternatively, the strong UPR induction measured
by HSP-4::GFP levels in ICD-1 depleted embryos likely led to the notable suppression of
protein synthesis under tunicamycin. To confirm that the robust translation attenuation in
ICD-1 depleted embryos is due to increased HSP-4 levels, FRAP must be performed in
tunicamycin -untreated embryos depleted of ICD-1 or ICD-2. This experiment would
also reveal whether disruption of a functional NAC by removal of either subunit leads to
equal levels of suppressed protein synthesis, indicating the difference obtained under ER
stress is a result of a stronger UPR induction in the ICD-1 depleted samples. In addition,
the FRAP recovery profile observed was only tested in a single pan neuronal marker.
Therefore to further confirm the results obtained, identical experiments must be
performed employing additional neuronal markers.
The UPR stimulates translation of ATF-4 during misfolded protein stress and
studies have shown ATF-4 directly up-regulates the expression of mammalian HSP-4
homologue GRP78/BiP32, 34. The robust translation attenuation observed in ICD-1
depleted embryos under stress is putatively accompanied by an increase in ATF-4, which,
in turn, may upregulate HSP-4. Consistently, the recovery of protein synthesis under
stress in ICD-2 depleted embryos is potentially due to faster de-repression of translation,
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resulting in decreasing levels of ATF4 and therefore HSP-4. To confirm these
predictions, ATF-4 levels must be monitored in C. elegans embryos depleted of either
ICD-1 or ICD-2 with an active UPR.
Although differences in expression of ER specific chaperone and attenuation of
protein synthesis under stress were observed in ICD-1 depleted embryos compared to
ICD-2 defective embryos (Figure 3 and Figure 11, respectively), depletion of either NAC
subunit resulted in equal levels of lysosomal presence (Figure 5). Lysosomal auto
fluorescent and HSP-4::GFP images were both analyzed via the fluorescence each
element generated. However, whole embryo Z-stacks were generated for HSP-4::GFP
samples and single plane images were generated to monitor differences in lysosomal
presence. Unlike exogenous fluorophores that are excited at a specific wavelength (as
would be true during analysis of HSP-4::GFP), the lysosomal granules were excited with
an external fluorescent light and images were captured using a blue filter, which allows
light of various wavelengths to be captured. Although the external light source was
maintained constant across all samples, the light source may have failed to induce the
appropriate excitation/emission spectrum of the auto fluorescent lysosomal granules.
Along with inappropriate excitation/emission, the filter employed may not have
exclusively captured the desired lysosomal structures. Therefore a more sensitive
technique for detection of lysosomal generation may detect differences in lysosomal
presence between ICD-1 and ICD-2 depleted embryos.
4.2 tunicamycin exposure leads to differences in neuronal development but not gut
cell development between ICD-1 and ICD-2 depleted embryos
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In addition to regulating protein homeostasis under stress, both α-NAC and
components of the UPR contribute to the differentiation of specific cell types68-74. To test
whether the individual subunits of the NAC vary in their contributions to differentiation
in conjunction with the UPR, the development of neuronal and gut cells was monitored in
C. elegans strains containing cell-type specific fluorescent reporters.
In early-stage embryos, all RNAi treatments resulted in decreased neuronal YFP
signal during sustained tunicamycin exposure compared to untreated samples. However,
ICD-1 depleted early embryos showed a significant decrease in YFP signal compared to
ICD-2 defective early embryos at 24 hours of tunicamycin exposure (Figure 12).
Comparable results were obtained in late-stage embryos: relative to untreated samples, all
RNAi treatments resulted in decreased neuronal YFP signal during sustained ER stress
with ICD-1 depleted samples showing a significant decrease compared to ICD-2 depleted
embryos at 12 hour tunicamycin exposure (Figure 14). During the significant YFP signal
reduction observed in ICD-1 depleted embryos, the diffuse YFP signal observed in other
treatments became punctate and localized to specific regions of early (Figure 13) and late
embryos (Figure 15). The difference in quantified neuronal YFP signal and localization
between ICD-1 and ICD-2 depleted embryos occurred during the same tunicamycin
exposure times that resulted in significant HSP-4 level differences between the two RNAi
treatments. At 12 hour tunicamycin exposure, average YFP pixel intensity in ICD-1
depleted late embryos was 1.5 times lower than ICD-2 defective embryos (Figure 14) and
average HSP-4::GFP pixel intensity in ICD-1 depleted embryos was 4 times greater than
ICD-2 defective embryos (Figure 3). At 24 hour tunicamycin exposure, average YFP
pixel intensity in ICD-1 depleted early embryos was 1.5 times lower than ICD-2
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defective embryos (Figure 12) and average HSP-4::GFP pixel intensity in ICD-1 depleted
embryos was 3.5 times greater than ICD-2 defective embryos (Figure 3). These
observations suggest that disruption of the NAC by depletion of ICD-1 leaves unbound
ICD-2 to contribute to the up regulation of HSP-4, which in turn, may alter the normal
developmental expression pattern of the specific neuronal marker employed.
The mammalian ICD-2 homologue α-NAC contributes to normal erythroid,
CD8+ T cell and osteoblast development; alterations to α-NAC, while β-NAC remains
unchanged, leads to altered differentiation in these cell types68, 69, 70. Therefore the
altered neuronal development observed in our experiments is likely a result of increased
levels of unbound ICD-2 in the ICD-1 depleted samples as ICD-2 depleted samples and
controls showed virtually equal neuronal differentiation timing. A concomitant increase
in HSP-4::GFP was observed during identical tunicamycin exposure times rendering
differences in neuronal development between ICD-1 and ICD-2 depleted samples,
suggesting an overactive UPR may be sufficient to alter normal cellular development.
Like α-NAC, several markers of an active UPR are present during erythroid, CD8+ T cell
and osteoblast differentiation71-74. Taken together, the results obtained suggest alterations
to the normal developmental expression pattern of neurons in C. elegans is a result of
greater levels of ICD-2 relative to ICD-1 accompanied by an overactive UPR.
Results from FRAP experiments for the specific neuronal marker employed
showed ICD-1 depletion led to a stronger suppression of protein synthesis during
tunicamycin -induced stress compared to ICD-2 depletion (Figure 11). An identical
nematode strain was employed to monitor neuronal development under ER stress in all
RNAi treatments. Therefore, the decreased neuronal signal in ICD-1 depleted embryos
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observed at 12 (late embryos) and 24 (early embryos) hours tunicamycin exposure may
be a reflection of the suppressed translation of the specific neuronal marker employed. If
true, a decrease in translation of cell specific markers may be considered inappropriately
as a deviation in differentiation. Throughout differentiation, embryos express cell
specific markers and a reduction in these markers may be an indication of a subset of
cells failing to do so, and attaining an altered cellular “identity”. The developmental
expression marker under ER stress of a single neuronal marker was monitored in this
study. To confirm the observations obtained, other global neuronal and neuron-type
specific markers must be similarly assessed.
Although tunicamycin exposure led to a significant reduction in neuronal marker
expression in ICD-1 depleted late-stage and early-stage embryos compared to ICD-2
depleted embryos (Figure 12 and Figure 14, respectively), no differences in gut cell
expression were found in early-stage or late-stage embryos with identical tunicamycin
exposure in either RNAi population (Figure 16 and Figure 17, respectively). This
equivalent gut cell development under stress paralleled a significant difference in HSP4::GFP levels between ICD-1 or ICD-2 depletion (Figure 3). In contrast to the
developmental expression of the neuronal marker employed under stress, these
observations suggest that the difference in the degree of this UPR induction marker was
not sufficient to alter the developmental expression of the gut cell marker employed.
However, a single gut cell lineage marker was assessed. To confirm the results obtained,
identical experiments should be performed employing a wide range of global gut cell
markers.
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4.3 Potential role of the C. elegans NAC during ER stress and implication for human
pathologies
Based on the hypothesized NAC function, disruption of a functional NAC
complex may induce the UPR due to inappropriate shuttling of proteins into the ER
lumen. Although previous studies have shown removal of either α- or β-NAC can
activate the UPR, the degree of UPR induction obtained with removal of one or the other
NAC subunit remains unexplored62, 63. The individual subunits of the NAC are predicted
to possess independent functions that are carried out when unbound from the functional
complex, suggesting the hypothesis that disruption of the NAC complex by removal of
either subunit leads to unbound levels of an individual subunit that is able to carry out a
distinct function57, 58. Based on this hypothesis, this study predicted to find differences in
major UPR outcomes and development in samples depleted of either α- or β-NAC with
an active UPR. Compared to controls, significant differences were found in ICD-1
depleted embryos (β-NAC) presumably containing increased levels of unbound ICD-2 (α
-NAC) with an active UPR. These embryos displayed increased HSP-4::GFP levels, a
robust suppression of protein synthesis and altered neuronal development relative to ICD2 (α -NAC) depleted samples. These results are consistent with a NAC subunit specific
degree of UPR induction during ER stress and suggest a specific characteristic of the
ICD-2 subunit (α -NAC) is responsible for the differences observed in our model system.
The role of α-NAC in mammalian bone development provides insights into the results
obtained in this study.
Northern blot analysis of developing osteoblast show α-NAC mRNA is higher
than that of β-NAC during normal bone development. In this cell type, α-NAC
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phosphorylation leads to nuclear translocation where α-NAC acts as a developmentally
regulated transcriptional co-activator for ATF4 mediated transcription70, 71. As a potent
transcription factor during ER stress, ATF4 regulates the expression of ERSE target
genes33. One of the ATF4 target genes is BiP, the mammalian HSP-4 homologue. ATF4
directly binds the GRP78/BiP promoter region to increase gene expression under stress34.
This observation is consistent with a previously presented model of an ATF4 mediated
HSP-4 up regulation in samples with elevated ICD-2 levels (icd-1 RNAi) and may
explain the differences in the degree of UPR induction obtained with removal of either C.
elegans NAC subunit. To investigate the potential interactions between ICD-2 and the C.
elegans ATF-4 homologue, a series of sequence alignments was performed to assess the
presence of essential functional features in these proteins.
Phosphorylation of serine 43 in the α-NAC is essential for nuclear translocation to
function as a transcriptional co-activator for ATF4 mediated transcription70, 71. A protein
sequence alignment (Clustal W) between ICD-2 and mammalian α-NAC reveals ICD-2
possesses several conserved serine residues (Figure 18). The functional mammalian
ATF4 possesses a conserved Leucine zipper domain composed of repeating Leucine
residues near the C’ terminus. In addition, ATF4 is up regulated under stress to induce
the expression of ERSE target genes such as the ER specific chaperone GRP78/BiP.
ATF5, the C. elegans homologue of ATF4, is also up regulated under ER stress to
presumably carry out a similar transcriptional induction of ERSE target genes85. The
sequence alignment performed suggests ICD-2 has the potential for nuclear translocation.
In the nucleus, ICD-2 may interact with ATF5 in a complex analogous to that observed
during mammalian bone development between α-NAC and ATF4. The predicted

66
interaction between ICD-2 and ATF5, with elevated levels of ATF5 and greater levels of
ICD-2 relative to ICD-1, may target ERSE genes including HSP-4 during ER stress. To
test this hypothesis, the outcomes assessed in this study should be tested in embryos
depleted of ICD-1 or ICD-2 with an active UPR and containing an ATF5 mutant
background. In such future study, the ATF5 mutant background is expected to
equilibrate the degree of UPR induction with removal of either subunit based on the
resulting outcomes from α-NAC/ATF4 interactions. Consistent with the data presented
in this study, the following model suggests a mechanism explaining the differences in the
degree of UPR induction obtained with greater levels of ICD-2 relative to ICD-1 (ICD-1
RNAi): (1) tunicamycin activates the UPR, (2) UPR translation attenuation leads to
preferential ATF5 translation and (3) ICD-2 phosphorylation leads to nuclear localization
and interactions with ATF5 resulting in increased HSP-4 expression, efficient translation
attenuation and altered differentiation (Figure 19).
Misfolded protein stress responses are major contributors to the “tipping point”
between cell survival and death1-4. Based on the functions of α-NAC and the UPR in
mitigating stress, it may not be surprising that α-NAC and UPR components are up
regulated in certain types of cancers34, 66, 67. Using C. elegans as a model system, this
study found disruption of a functional NAC complex rendering increased unbound αNAC levels lead to a robust protective response under ER stress. Alterations to α-NAC
levels is unlikely the only contributor of a potent UPR under stress. However, a better
understanding of the role these factors play on determining the “tipping point” between
cell survival and death may help elucidate novel therapeutic targets for diseases
exhibiting hyperactive UPR. The increased GRP78/BiP expression documented in tumor
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cells is likely representative of a hyperactive protective response under ER stress and
reflects a “tipping point” predisposed towards survival. Based on previous studies and
the data presented in this study, NAC may serve as a target for reconstituting the
appropriate “tipping point” in cells predisposed towards survival66, 67. Given the
complexity of the different components of the UPR, it is likely that α-NAC interacts
differently with each arm of the UPR. C.elegans provide an appropriate system to
explore the direction in which the “tipping point” is predisposed in samples defective of
certain UPR components. A lucid understanding of the mechanism by which interactions
between α-NAC and individual UPR components affect cell fate will provide further
potential therapeutic targets for diseases exhibiting alterations in UPR activity, such as
neurodegeneration and cancer.
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Figure 18: Protein sequence alignment of mammalian α-NAC and C. elegans icd2. A protein sequence alignment (Clustal W) was performed to compare the amino
acid sequence composition of mammalian α-NAC (Hs_Nac_a) and C. elegans ICD-2
(Ce_ICD-2).
2). Asterisks denote conserved serine residues amongst the two protein
sequences

69

Figure 19: Proposed mechanism for differences in the degree of UPR induction
obtained with elevated ICD
ICD-2 levels. (1) Tunicamycin activates the UPR, (2) UPR
translation attenuation leads to preferential ATF
ATF-5
5 translation and (3) ICD-2
ICD
phosphorylation leads to nuclear localization and interactions with ATF
ATF-5
5 resulting
in increased HSP-44 expression, efficient translatio
translation
n attenuation and altered
differentiation
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